ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31920-10mg |
|
36204-23-6 |
Fibrinopeptide B, human (FPB,human)
|
0 | C66H93N19O25 | |
GC31920-5mg |
|
36204-23-6 |
Fibrinopeptide B, human (FPB,human)
|
0 | C66H93N19O25 | |
GC31920-1mg |
|
36204-23-6 |
Fibrinopeptide B, human (FPB,human)
|
0 | C66H93N19O25 | |
GC31919-10mg |
|
1005549-94-9 |
Taprenepag isopropyl (PF-04217329)
|
0 | C27H28N4O5S | |
GC31919-5mg |
|
1005549-94-9 |
Taprenepag isopropyl (PF-04217329)
|
0 | C27H28N4O5S | |
GC31918-10mg |
|
93135-89-8 |
Nafocare B1 (Methylfurylbutyrolactone)
|
0 | C11H12O7 | |
GC31918-5mg |
|
93135-89-8 |
Nafocare B1 (Methylfurylbutyrolactone)
|
0 | C11H12O7 | |
GC31918-1mg |
|
93135-89-8 |
Nafocare B1 (Methylfurylbutyrolactone)
|
0 | C11H12O7 | |
GC31917-10mg |
|
93363-11-2 |
48740 RP (RP-55778)
|
0 | C12H11N3OS | |
GC31917-5mg |
|
93363-11-2 |
48740 RP (RP-55778)
|
0 | C12H11N3OS | |
GC31917-1mg |
|
93363-11-2 |
48740 RP (RP-55778)
|
0 | C12H11N3OS | |
GC31916-10mg |
|
212370-40-6 |
Gp100 (25-33), human
|
0 | C52H82N16O14 | |
GC31916-5mg |
|
212370-40-6 |
Gp100 (25-33), human
|
0 | C52H82N16O14 | |
GC31916-1mg |
|
212370-40-6 |
Gp100 (25-33), human
|
0 | C52H82N16O14 | |
GC31915-5mg |
|
101155-02-6 |
BW-A 78U
|
0 | C13H12FN5 | |
GC31915-1mg |
|
101155-02-6 |
BW-A 78U
|
0 | C13H12FN5 | |
GC31915-10mM(1mLinDMSO) |
|
101155-02-6 |
BW-A 78U
|
0 | C13H12FN5 | |
GC31914-50mg |
|
2132396-40-6 |
CD73-IN-1
|
0 | C18H17N3O4S | |
GC31914-25mg |
|
2132396-40-6 |
CD73-IN-1
|
0 | C18H17N3O4S | |
GC31914-10mg |
|
2132396-40-6 |
CD73-IN-1
|
0 | C18H17N3O4S | |